These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3899669)

  • 61. Acute haemodynamic effects of pinacidil in man.
    Nicholls DP; Murtagh JG; Scott ME; Morton P; Shanks RG
    Br J Clin Pharmacol; 1986 Sep; 22(3):287-92. PubMed ID: 3768241
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension.
    Steensgaard-Hansen F; Carlsen JE
    Drugs; 1988; 36 Suppl 7():70-6. PubMed ID: 3254831
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension.
    Goldberg MR; Rockhold FW; Thompson WL; DeSante KA
    J Clin Pharmacol; 1989 Jan; 29(1):33-40. PubMed ID: 2708546
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the effects of muzolimine and a fixed combination of diuretics in essential hypertension.
    Wicker P; Clementy J
    Clin Pharmacol Ther; 1986 May; 39(5):537-42. PubMed ID: 3516511
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary evaluation of pinacidil in hypertension.
    Ramsay LE; Freestone S
    Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of pindolol on blood pressure, plasma renin activity, and catecholamines in hypertensive patients.
    Gavras I; Gavras H; Tifft CP; Kershaw GR; Bresnahan M
    J Clin Pharmacol; 1981; 21(2):79-83. PubMed ID: 7014658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.
    Hansson BG; Dymling JF; Hedeland H; Hulthén UL
    Eur J Clin Pharmacol; 1977 Apr; 11(4):239-45. PubMed ID: 324771
    [No Abstract]   [Full Text] [Related]  

  • 68. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potassium channel modulation: effect of pinacidil on insulin release in healthy volunteers.
    Links TP; Smit AJ; Reitsma WD
    J Clin Pharmacol; 1995 Mar; 35(3):291-4. PubMed ID: 7608319
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of furosemide and chlorothiazide on blood pressure and plasma renin activity.
    Saito I; Misumi J; Kondo K; Saruta T; Matsuki S
    Cardiovasc Res; 1976 Mar; 10(2):149-52. PubMed ID: 938983
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    Acta Med Scand; 1988; 223(2):125-31. PubMed ID: 3279724
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of L-dopa in young patients with hypertension.
    Saito I; Kawabe H; Hasegawa C; Iwaida Y; Yamakawa H; Saruta T; Takeshita E; Nagano S; Sekihara T
    Angiology; 1991 Sep; 42(9):691-5. PubMed ID: 1928809
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.
    Carlsen JE; Kardel T; Hilden T; Tangø M; Trap-Jensen J
    Clin Physiol; 1981 Aug; 1(4):375-84. PubMed ID: 7199409
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
    Jordan J; Engeli S; Boye SW; Le Breton S; Keefe DL
    Hypertension; 2007 May; 49(5):1047-55. PubMed ID: 17353513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of reserpine and dihydrazinophthalazine on cerebrospinal fluid and blood catecholamines in the hypertensive disease.
    Ciplea A; Bubuianu G
    Rev Roum Physiol; 1969; 6(4):267-74. PubMed ID: 4926779
    [No Abstract]   [Full Text] [Related]  

  • 77. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
    Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term effects of pinacidil in hypertensive dialysis patients.
    Breen EG; Mulhall D; Keogh JA
    Eur J Clin Pharmacol; 1985; 28(4):375-80. PubMed ID: 4029243
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.
    Krum H; Viskoper RJ; Lacourciere Y; Budde M; Charlon V
    N Engl J Med; 1998 Mar; 338(12):784-90. PubMed ID: 9504938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.